Status:
COMPLETED
Use Of Valproid Acid To Treat Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM)
Lead Sponsor:
University of Sao Paulo
Conditions:
Paraparesis Spastic Tropical
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
Is the valproic acid efficacy to treat TSP/HAM
Eligibility Criteria
Inclusion
- HTLV-1; TSP/HAM fulfill criteria
Exclusion
- Age \<18 years
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00681980
Start Date
February 1 2008
End Date
December 1 2015
Last Update
December 3 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Tropical Medicine at Sao Paulo University
São Paulo, São Paulo, Brazil, 0543903